Unknown PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT00695240

Post-Operative Pain Control Using Direct Continuous Bupivacaine Infusion After Pelvic Organ Prolapse Repair

Sponsor: St. Luke's Hospital, Kansas City, Missouri

Conditions Pelvic Organ Prolapse Post-Operative Pain

Interventions Continuous bupivacaine analgesia infusion (ON-Q PainBuster Post-Op Pain Relief System)

Updated 6 times since 2017 Last updated: Jun 10, 2008 Started: Apr 30, 2007 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00695240, this PHASE2/PHASE3 trial focuses on Pelvic Organ Prolapse and Post-Operative Pain and remains ongoing. Sponsored by St. Luke's Hospital, Kansas City, Missouri, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Luke's Hospital, Kansas City, Missouri

Data source: St. Luke's Hospital, Kansas City, Missouri

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansas City, United States